ABL Diagnostics and ProPhase Labs announce non-binding LOI for proposed reverse merger
ABL Diagnostics has announced that its controlling shareholder, Advanced Biological Laboratories S.A., and ProPhase Labs, (NASDAQ:PRPH) have entered into a non-binding letter of intent (LOI) for a proposed reverse merger.










